By Mill Chart
Last update: Aug 12, 2025
Technical breakout strategies focus on identifying stocks with solid momentum that are consolidating before their next upward move. The method uses two main metrics: the ChartMill Technical Rating, which measures a stock’s overall trend strength, and the ChartMill Setup Quality Rating, which checks if the stock is forming a high-probability consolidation pattern. Stocks with high scores in both areas often offer good risk-reward setups for traders.
BRIDGEBIO PHARMA INC (NASDAQ:BBIO) stands out in this approach, with a Technical Rating of 10 and a Setup Rating of 9, indicating strong trend health and a clear entry opportunity.
The Technical Rating looks at factors like relative strength, trend consistency, and moving average alignment. BBIO performs well in these areas:
For breakout traders, a high Technical Rating lowers the risk of entering a weakening trend. BBIO’s consistency across timeframes points to institutional support and reduces the chance of sudden reversals.
The Setup Rating checks if a stock is poised for a breakout. BBIO’s score of 9 reflects an ideal consolidation pattern:
The setup suggests an entry above $49.78 (the 10-day high), aiming for a breakout, with a stop-loss just below $45.58 to limit downside to ~8.4%. The tight risk range, combined with high relative strength, makes the trade appealing.
Breakout systems succeed with two conditions:
The stock’s mix of sector-leading momentum and a high-probability setup matches historical breakout winners, which often come from similar patterns.
For traders looking for more opportunities, the Technical Breakout Setups screen updates daily with new candidates meeting these criteria.
Disclaimer: This analysis is not investment advice. Always do your own research and consider risk tolerance before trading. Past performance does not guarantee future results.
49.09
+0.85 (+1.76%)
Find more stocks in the Stock Screener